angiotensin ii has been researched along with Cancer of Pancreas in 41 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (19.51) | 18.7374 |
1990's | 9 (21.95) | 18.2507 |
2000's | 17 (41.46) | 29.6817 |
2010's | 6 (14.63) | 24.3611 |
2020's | 1 (2.44) | 2.80 |
Authors | Studies |
---|---|
Asgharzadeh, F; Avan, A; Ferns, GA; Geraylow, KR; Hassanian, SM; Khazaei, M; Nassiri, M | 1 |
Chan, SMH; Herbert, TP; Ku, JM; Lau, YS; Miller, AA; Potocnik, S; Woodman, OL; Ye, JM | 1 |
Cordopatis, P; Inui, M; Ishiguro, S; Kawabata, A; Magafa, V; Oka, M; Takao, S; Tamura, M; Tsunedomi, R; Tzakos, AG; Wall, T; Yoshimura, K | 1 |
Chodavarapu, H; Lazartigues, E; Pedersen, KB; Porretta, C; Robinson, LK | 1 |
Qian, A; Qiao, M; Wang, J; Yao, W; Yuan, Y; Zhang, R; Zhang, Y; Zhou, L | 1 |
Greish, K; Maeda, H; Nagamitsu, A | 1 |
Arafat, HA; Aziz, T; Chehl, N; Chipitsyna, G; Gong, Q; Yeo, CJ | 1 |
Lau, ST; Leung, PS | 1 |
Gutierréz-Reyes, G; Guzmán, C; Hiriart, M; Olivares-Reyes, JA; Pérez-Díaz, I; Ramírez, T; Robles-Díaz, G | 1 |
Arends, J; Büchert, M; Fasol, U; Fiedler, U; Frost, A; Mross, K; Scharr, D; Scheuenpflug, J | 1 |
Amaya, K; Fujimura, T; Fushida, S; Kayahara, M; Kitagawa, H; Miwa, K; Ninomiya, I; Nishimura, G; Ohta, T; Shimizu, K; Yi, S | 2 |
Baba, Y; Hayashi, S; Ishikawa, T; Kamimura, T; Nomura, K; Oota, H; Yoshida, T | 1 |
Imaoka, S; Ishikawa, O; Nakaizumi, A; Ohigashi, H; Sasaki, Y; Uehara, H; Yamada, T; Yokayama, S | 1 |
Amaya, K; Fujimura, T; Kayahara, M; Kitagawa, H; Miwa, K; Nishimura, G; Ohta, T; Shimizu, K; Takamura, H | 1 |
Bussink, M; Menheere, PP; van der Kuy, PH; van Mook, WN; van Onzenoort, HA | 1 |
Arafat, HA; Chipitsyna, G; Gong, Q; Gray, CF; Haroon, Y; Kamer, E | 1 |
Kisfalvi, K; Rey, O; Rozengurt, E; Sinnett-Smith, J; Young, SH | 1 |
Arafat, HA; Chipitsyna, G; Gong, Q; Rizvi, A; Saa, CT; Yeo, CJ | 1 |
Ishikawa, T; Kamimura, H; Kamimura, T; Ohta, H; Seki, K; Takeda, K; Togashi, T; Tsuchiya, A; Ushiki, T; Watanabe, K; Yoshida, T | 1 |
Anandanadesan, R; Arafat, HA; Chipitsyna, G; Gong, Q; Witkiewicz, A; Yeo, CJ | 1 |
Ishikawa, T; Kamimura, H; Kamimura, T; Ohta, H; Seki, K; Takeda, K; Togashi, T; Tsuchiya, A; Watanabe, K; Yoshida, T | 1 |
Fujimoto, S; Ishigami, H; Minami, T; Miyazaki, M; Ohyama, N; Okui, K; Takahashi, M | 1 |
Robertson, JI | 1 |
Hoshi, M; Sato, H | 1 |
Furukawa, H; Hiratsuka, M; Imaoka, S; Ishikawa, O; Kabuto, T; Kameyama, M; Masutani, S; Nakamori, S; Ohigashi, H; Sasaki, Y | 2 |
Furukawa, H; Hiratsuka, M; Imaoka, S; Ishikawa, O; Iwanaga, T; Kabuto, T; Kameyama, M; Nakamori, S; Nakano, H; Ohigashi, H; Sasaki, Y; Tsuji, Y; Yasuda, T | 1 |
Fujita, M; Furukawa, H; Hiratsuka, M; Imaoka, S; Ishikawa, O; Kabuto, T; Kameyama, M; Kuroda, C; Nakamori, S; Nakano, H; Ohigashi, H; Sasaki, Y; Yasuda, T | 1 |
Fujita, M; Hosomi, N; Inoue, E; Ishiguro, S; Ishikawa, O; Kuroda, C; Mihara, N; Nakaizumi, A; Ohigashi, H | 1 |
Fujita, M; Furukawa, H; Hiratsuka, M; Hosomi, N; Imaoka, S; Ishikawa, O; Kabuto, T; Kameyama, M; Kuroda, C; Murata, K; Nakaizumi, A; Nakano, H; Ohigashi, H; Sasaki, Y; Uehara, H; Yasuda, T | 1 |
Ishikawa, T; Matsui, S; Matsuki, H; Matsuzawa, J; Mita, Y; Sato, S; Tashiro, K; Tashiro, S | 1 |
Chayama, K; Fujimoto, Y; Sasaki, T; Tsuchida, A | 1 |
Novak, D; Weber, J | 1 |
Fukuda, I; Furukawa, H; Hiratsuka, M; Imaoka, S; Ishikawa, O; Kabuto, T; Kameyama, M; Masutani, S; Ohigashi, H; Sasaki, Y | 1 |
Kakizaki, K; Yamauchi, H | 1 |
Asamura, M; Kakizaki, K; Kikuti, H; Takahashi, N; Yamauchi, H | 1 |
Furukawa, H; Hiratsuka, M; Imaoka, S; Ishikawa, O; Iwanaga, T; Kabuto, T; Ohigashi, H; Sasaki, Y; Shibata, T; Yasuda, T | 1 |
Kai, Y; Koura, Y; Kurisu, Y; Kuroi, K; Maruyama, T | 1 |
Ishikawa, O; Iwanaga, T; Ohhigashi, H | 1 |
Bookstein, JJ; Kaplan, JH | 1 |
2 review(s) available for angiotensin ii and Cancer of Pancreas
Article | Year |
---|---|
Role of the RAS in pancreatic cancer.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Humans; Pancreatic Neoplasms; Receptor, Angiotensin, Type 1; Renin-Angiotensin System | 2011 |
Renin-secreting tumour.
Topics: Adenocarcinoma; Adult; Aldosterone; Angiotensin II; Animals; Blood Pressure; Child; Dogs; Hemangiopericytoma; Humans; Kidney Neoplasms; Pancreatic Neoplasms; Renin; Renin-Angiotensin System | 1984 |
3 trial(s) available for angiotensin ii and Cancer of Pancreas
Article | Year |
---|---|
Vascular and pharmacokinetic effects of EndoTAG-1 in patients with advanced cancer and liver metastasis.
Topics: Adult; Aged; Angiogenesis Inhibitors; Angiotensin II; Area Under Curve; Breast Neoplasms; Colorectal Neoplasms; Contrast Media; Endothelin-1; Female; Humans; Interleukins; Liposomes; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Paclitaxel; Pancreatic Neoplasms; Ultrasonography; Vascular Endothelial Growth Factor A | 2012 |
Angiotensin-II administration is useful for the detection of liver metastasis from pancreatic cancer during pharmacoangiographic computed tomography.
Topics: Adult; Aged; Aged, 80 and over; Angiography; Angiotensin II; Celiac Artery; Female; Humans; Liver Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Prospective Studies; Tomography, Spiral Computed; Vasoconstrictor Agents | 2007 |
Angiotensin II-induced hypertension chemotherapy (IHC) for advanced gastrointestinal, pancreatic and hepatobiliary carcinoma.
Topics: Angiotensin II; Biliary Tract Neoplasms; Gastrointestinal Neoplasms; Humans; Hypertension; Liver Neoplasms; Pancreatic Neoplasms | 1995 |
36 other study(ies) available for angiotensin ii and Cancer of Pancreas
Article | Year |
---|---|
Angiotensin-converting Enzyme Inhibitors and Angiotensin Receptor Blockers as Potential Therapeutic Options for Pancreatic Cancer.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Humans; Pancreatic Neoplasms; Prospective Studies | 2022 |
Angiotensin II Causes β-Cell Dysfunction Through an ER Stress-Induced Proinflammatory Response.
Topics: Angiotensin II; Animals; Cell Line, Tumor; Cytokines; Diabetes Mellitus, Type 2; eIF-2 Kinase; Endoplasmic Reticulum Stress; Endoribonucleases; Gene Expression; Gene Knockdown Techniques; Glucose; Inflammation; Inositol 1,4,5-Trisphosphate Receptors; Insulin-Secreting Cells; Insulinoma; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Pancreatic Neoplasms; Protein Serine-Threonine Kinases; Reactive Oxygen Species; Renin-Angiotensin System; RNA, Small Interfering; Taurine; Ursodeoxycholic Acid | 2017 |
Involvement of angiotensin II type 2 receptor (AT2R) signaling in human pancreatic ductal adenocarcinoma (PDAC): a novel AT2R agonist effectively attenuates growth of PDAC grafts in mice.
Topics: Angiotensin II; Animals; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Gene Expression; Humans; Immunohistochemistry; Mice; Pancreatic Neoplasms; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Signal Transduction; Transplantation, Isogeneic; Tumor Burden; Tumor Stem Cell Assay | 2015 |
Dynamics of ADAM17-Mediated Shedding of ACE2 Applied to Pancreatic Islets of Male db/db Mice.
Topics: ADAM Proteins; ADAM17 Protein; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cell Line, Tumor; Cell Membrane; Diabetes Mellitus; Diabetes Mellitus, Experimental; Disease Progression; Insulin-Secreting Cells; Insulinoma; Islets of Langerhans; Male; Mice; Pancreatic Neoplasms; Peptidyl-Dipeptidase A; Rats; RNA, Messenger | 2015 |
Decreased expression of angiotensin-converting enzyme 2 in pancreatic ductal adenocarcinoma is associated with tumor progression.
Topics: Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme 2; Blotting, Western; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Disease Progression; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Middle Aged; Pancreatic Neoplasms; Peptidyl-Dipeptidase A; Protein Transport; RNA Interference | 2009 |
Elevating blood pressure as a strategy to increase tumor-targeted delivery of macromolecular drug SMANCS: cases of advanced solid tumors.
Topics: Adenocarcinoma; Adult; Aged; Angiotensin II; Antineoplastic Agents; Blood Pressure; Carcinoma, Renal Cell; Cholangiocarcinoma; Drug Delivery Systems; Female; Humans; Hypertension; Infusions, Intravenous; Japan; Kidney Neoplasms; Liver Neoplasms; Male; Maleic Anhydrides; Middle Aged; Neoplasm Staging; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Polystyrenes; Vasoconstrictor Agents; Zinostatin | 2009 |
Angiotensin II regulates the expression of monocyte chemoattractant protein-1 in pancreatic cancer cells.
Topics: Adenocarcinoma; Angiotensin II; Blotting, Western; Cell Line, Tumor; Chemokine CCL2; Extracellular Signal-Regulated MAP Kinases; Gene Expression; Humans; Immunohistochemistry; Inflammation; Losartan; NF-kappa B; Pancreatic Neoplasms; Promoter Regions, Genetic; Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Transcription, Genetic; Tumor Cells, Cultured | 2009 |
Evidence of an intracellular angiotensin-generating system and non-AT1, non-AT2 binding site in a human pancreatic cell line.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Binding Sites; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Humans; Intracellular Space; Losartan; Pancreatic Neoplasms; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Vascular Endothelial Growth Factor A | 2011 |
[Intrinsic angiotensin II-generating system in human pancreatic cancer tissues].
Topics: Adult; Aged; Angiotensin II; Carcinoma, Hepatocellular; Colonic Neoplasms; Female; Histocytochemistry; Humans; Liver Neoplasms; Male; Middle Aged; Pancreas; Pancreatic Neoplasms; Peptidyl-Dipeptidase A | 2002 |
Angiotensin converting enzyme-independent, local angiotensin II-generation in human pancreatic ductal cancer tissues.
Topics: Angiotensin II; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Chymases; Colonic Neoplasms; Humans; Hydrogen-Ion Concentration; Immunohistochemistry; Liver Neoplasms; Mast Cells; Pancreas; Pancreatic Neoplasms; Peptidyl-Dipeptidase A; Serine Endopeptidases; Trypsin | 2003 |
[A case of advanced gastric cancer with liver and intra-abdominal lymph node metastasis treated by hypertensive selective chemotherapy with pharmacokinetic modulating chemotherapy].
Topics: Adenocarcinoma; Aged; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Pancreatic Neoplasms; Stomach Neoplasms; Tegafur | 2003 |
Intra-arterial infusion chemotherapy with angiotensin-II for locally advanced and nonresectable pancreatic adenocarcinoma: further evaluation and prognostic implications.
Topics: Adenocarcinoma; Adult; Aged; Angiotensin II; Chi-Square Distribution; Female; Humans; Infusions, Intra-Arterial; Male; Methotrexate; Middle Aged; Pancreatic Neoplasms; Prognosis; Statistics, Nonparametric; Survival Analysis; Vasoconstrictor Agents | 2003 |
Angiotensin II activates MAP kinase and NF-kappaB through angiotensin II type I receptor in human pancreatic cancer cells.
Topics: Aged; Angiotensin II; Apoptosis; bcl-X Protein; Cell Line, Tumor; Enzyme Activation; Humans; Inhibitor of Apoptosis Proteins; Microtubule-Associated Proteins; Middle Aged; Mitogen-Activated Protein Kinases; Neoplasm Proteins; NF-kappa B; Pancreatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Receptor, Angiotensin, Type 1; Signal Transduction; Survivin | 2004 |
The effect of sublingual captopril versus intravenous enalaprilat on angiotensin II plasma levels.
Topics: Adenocarcinoma; Administration, Sublingual; Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalaprilat; Female; Humans; Injections, Intravenous; Intestinal Polyposis; Pancreatic Neoplasms; Parenteral Nutrition | 2006 |
Induction of monocyte chemoattractant protein-1 expression by angiotensin II in the pancreatic islets and beta-cells.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Line, Tumor; Chemokine CCL2; Diabetes Mellitus, Type 1; Gene Expression; Hyperglycemia; Imidazoles; Insulin-Secreting Cells; Insulinoma; Interleukin-1beta; Losartan; Mice; Mice, Inbred NOD; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Pancreatic Neoplasms; Promoter Regions, Genetic; Protein-Tyrosine Kinases; Pyridines; Rats; Receptor, Angiotensin, Type 1; RNA, Messenger; Vasoconstrictor Agents | 2007 |
Insulin potentiates Ca2+ signaling and phosphatidylinositol 4,5-bisphosphate hydrolysis induced by Gq protein-coupled receptor agonists through an mTOR-dependent pathway.
Topics: Angiotensin II; Blotting, Western; Bombesin; Bradykinin; Calcium Signaling; Cell Line, Tumor; Dose-Response Relationship, Drug; Humans; Hydrolysis; Inositol 1,4,5-Trisphosphate; Insulin; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Microscopy, Fluorescence; Myristoylated Alanine-Rich C Kinase Substrate; Neurotensin; Pancreatic Neoplasms; Phosphatidylinositol 4,5-Diphosphate; Phosphorylation; Protein Kinases; Receptors, G-Protein-Coupled; Sirolimus; TOR Serine-Threonine Kinases; Vasopressins | 2007 |
Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blotting, Western; Carcinoma, Pancreatic Ductal; Chi-Square Distribution; Enzyme-Linked Immunosorbent Assay; Humans; Immunohistochemistry; Neovascularization, Pathologic; Pancreatic Neoplasms; Peptidyl-Dipeptidase A; Reverse Transcriptase Polymerase Chain Reaction; Treatment Outcome; Vascular Endothelial Growth Factor A | 2007 |
Angiotensin II induces vascular endothelial growth factor in pancreatic cancer cells through an angiotensin II type 1 receptor and ERK1/2 signaling.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Blotting, Western; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Disease Progression; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation, Neoplastic; Genistein; Humans; Imidazoles; Immunohistochemistry; Losartan; Mitogen-Activated Protein Kinase 1; Neovascularization, Pathologic; Pancreatic Neoplasms; Protein Kinase Inhibitors; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Signal Transduction; Vascular Endothelial Growth Factor A; Vasoconstrictor Agents | 2008 |
Clinical efficacy of intra-arterial pharmacokinetic chemotherapy with 5-fluorouracil, CDDP, gemcitabine, and angiotensin-II in patients with advanced pancreatic cancer.
Topics: Angiotensin II; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; CA-19-9 Antigen; Chemotherapy, Cancer, Regional Perfusion; Deoxycytidine; Female; Fluorouracil; Gemcitabine; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Treatment Outcome | 2007 |
[Clinical-pharmacological effects of angiotensin II upon intra-arterial infusion cancer chemotherapy (author's transl)].
Topics: Angiotensin II; Antineoplastic Agents; Carcinoma, Hepatocellular; Humans; Infusions, Intra-Arterial; Liver Circulation; Liver Neoplasms; Pancreatic Neoplasms; Stomach Neoplasms | 1981 |
[Evaluation of intra-arterial infusion chemotherapy and radical pancreatectomy in patients with locally advanced pancreatic cancer].
Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Doxorubicin; Drug Administration Schedule; Fluorouracil; Humans; Infusions, Intra-Arterial; Methotrexate; Neoplasm Invasiveness; Pancreatectomy; Pancreatic Neoplasms; Survival Rate | 1993 |
[A case of non-resectable pancreatic cancer surviving more than 4 years by intra-arterial infusion chemotherapy with angiotensin-II].
Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ductal, Breast; Combined Modality Therapy; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Methotrexate; Middle Aged; Pancreatic Neoplasms; Survivors | 1996 |
[A case report of preoperative intra-arterial infusion chemotherapy for pancreatic head carcinoma].
Topics: Adenocarcinoma; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Fluorouracil; Humans; Infusions, Intra-Arterial; Male; Methotrexate; Middle Aged; Pancreatic Neoplasms; Vasoconstrictor Agents | 1997 |
Spiral CT during pharmacoangiography with angiotensin II in patients with pancreatic disease. Technique and diagnostic efficacy.
Topics: Adult; Aged; Angiography; Angiotensin II; Female; Humans; Male; Middle Aged; Pancreas; Pancreatic Neoplasms; Pancreatitis; Regional Blood Flow; Tomography, X-Ray Computed | 1998 |
[A measure to continue intra-arterial infusion chemotherapy long-term for locally advanced pancreatic cancer].
Topics: Angiotensin II; Antimetabolites, Antineoplastic; Catheters, Indwelling; Drug Administration Schedule; Female; Heparin; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Methotrexate; Middle Aged; Pancreatic Neoplasms | 1998 |
[A case of successful management of nonresectable pancreas cancer with liver metastasis by intra-arterial infusion chemotherapy with angiotensin-II and administration of tegafur/uracil].
Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Methotrexate; Middle Aged; Pancreatic Neoplasms; Tegafur; Uracil | 2001 |
Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Cell Division; Dose-Response Relationship, Drug; Humans; Imidazoles; Pancreatic Neoplasms; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Tetrazoles; Transcription, Genetic; Tumor Cells, Cultured | 2001 |
[Pharmaco-angiography with angiotensin (author's transl)].
Topics: Adenocarcinoma; Angiography; Angiotensin II; Axilla; Celiac Artery; Hepatic Artery; Humans; Injections, Intra-Arterial; Kidney Neoplasms; Pancreatic Neoplasms; Pancreatitis; Prospective Studies; Regional Blood Flow; Renal Artery; Soft Tissue Neoplasms | 1976 |
[Evaluation of radiation therapy combined with intra-arterial infusion chemotherapy in patients with non-resectable pancreatic cancer].
Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Catheters, Indwelling; Combined Modality Therapy; Fluorouracil; Humans; Infusions, Intra-Arterial; Leucovorin; Methotrexate; Pancreatic Neoplasms; Radiotherapy, High-Energy; Retrospective Studies; Survival Rate | 1992 |
[Hepatic arterial infusion chemotherapy and loco-regional treatment and irradiation of pancreas tumor in non-resectable pancreas cancer with liver metastases].
Topics: Administration, Oral; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Leucovorin; Liver Neoplasms; Methotrexate; Pancreatic Neoplasms; Radiotherapy, High-Energy | 1991 |
[Long-term arterial infusion chemotherapy combined with external irradiation therapy for unresectable pancreatic cancer--a case report].
Topics: Adenocarcinoma; Aged; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Fluorouracil; Humans; Infusions, Intra-Arterial; Male; Mitomycin; Mitomycins; Pancreatic Neoplasms | 1991 |
[Long-term arterial infusion chemotherapy in unresectable pancreatic cancer].
Topics: Aged; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Fluorouracil; Humans; Infusion Pumps; Infusions, Intra-Arterial; Male; Middle Aged; Mitomycin; Mitomycins; Pancreatic Neoplasms; Subrenal Capsule Assay; Tissue Distribution | 1989 |
[Preventive effects of intra-arterial infusion chemotherapy of liver metastasis in non-resectable pancreatic cancer].
Topics: Alprostadil; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Humans; Infusions, Intra-Arterial; Leucovorin; Liver Neoplasms; Male; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Pancreatic Neoplasms; Portal Vein | 1989 |
[Intra-arterial infusion chemotherapy in non-resectable pancreatic cancer using angiotensin-II and implantable drug delivery system].
Topics: Adenoma, Bile Duct; Adult; Aged; Aged, 80 and over; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Female; Fluorouracil; Humans; Infusion Pumps; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Pancreatic Neoplasms | 1989 |
[Intra-arterial infusion chemotherapy for non-resectable pancreatic cancer using angiotensin-II and prostaglandin-E1].
Topics: Adult; Aged; Alprostadil; Angiography; Angiotensin II; Catheterization; Drug Administration Schedule; Female; Humans; Infusions, Intra-Arterial; Male; Methotrexate; Middle Aged; Pancreas; Pancreatic Neoplasms; Prognosis; Prostaglandins E; Regional Blood Flow | 1985 |
Abdominal visceral pharmacoangiography with angiotensin.
Topics: Adenoma, Islet Cell; Angiography; Angiotensin II; Blood Pressure; Carcinoma; Contrast Media; Humans; Intestines; Liver Circulation; Pancreatic Neoplasms; Pulse; Regional Blood Flow; Spleen; Stomach | 1972 |